Listen for Questions About Meds to Prevent RSV in Young Children

Nirsevimab-alip (Beyfortus) will be a new med to prevent respiratory syncytial virus (RSV) in young children.

You’ll hear nirsevimab called a vaccine...since it’s an intramuscular (IM) injection that provides protection against RSV. But it’s a monoclonal antibody that’s given in a clinic or hospital.

Nirsevimab joins palivizumab (Synagis)...another injectable monoclonal antibody to prevent serious illness from RSV.